Skip to main content

Moors & Cabot, Inc.

SEC CIK
0001607239
Latest filing
Aug 10, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
55,165
Value
$4.99M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of EW by Moors & Cabot, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202655,165$4.99M0.2%+852+1.6%AddedHolders
Q1 202654,313$4.35M0.2%−959−1.7%ReducedHolders
Q4 202555,272$4.71M0.2%+945+1.7%AddedHolders
Q3 202554,327$4.23M0.2%+578+1.1%AddedHolders
Q2 202553,749$4.20M0.2%+225+0.4%AddedHolders
Q1 202553,524$3.88M0.2%−1,065−2.0%ReducedHolders
Q4 202454,589$4.04M0.2%+152+0.3%AddedHolders
Q3 202454,437$3.59M0.2%−75−0.1%ReducedHolders
Q2 202454,512$5.04M0.3%+1,063+2.0%AddedHolders
Q1 202453,449$5.11M0.3%+2,950+5.8%AddedHolders
Q4 202350,499$3.85M0.2%+1,584+3.2%AddedHolders
Q3 202348,915$3.39M0.2%−705−1.4%ReducedHolders
Q2 202349,620$4.68M0.3%+208+0.4%AddedHolders
Q1 202349,412$4.09M0.3%+652+1.3%AddedHolders
Q4 202248,760$3.64M0.3%+80+0.2%AddedHolders
Q3 202248,680$4.02M0.3%−1,572−3.1%ReducedHolders
Q2 202250,252$4.78M0.3%−62−0.1%ReducedHolders
Q1 202250,314$5.92M0.4%−1,025−2.0%ReducedHolders
Q4 202151,339$6.65M0.4%−1,863−3.5%ReducedHolders
Q3 202153,202$6.02M0.4%−322−0.6%ReducedHolders
Q2 202153,524$5.54M0.4%+434+0.8%AddedHolders
Q1 202153,090$4.44M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.